INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 195 filers reported holding INSMED INC in Q2 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,368 | +19.7% | 173 | 0.0% | 0.00% | – |
| Q2 2023 | $3,650 | +511.4% | 173 | +394.3% | 0.00% | – |
| Q1 2023 | $597 | -70.2% | 35 | -69.6% | 0.00% | – |
| Q3 2022 | $2,000 | – | 115 | +1542.9% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 7 | -84.1% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 44 | +2.3% | 0.00% | – |
| Q2 2020 | $1,000 | -66.7% | 43 | -68.8% | 0.00% | – |
| Q4 2019 | $3,000 | – | 138 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |